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BACKGROUND: HIV infection is strongly associated to ED in men1,2. Preliminary data suggests that ED is poorly associated 
with serum T in HIV+ men1,3-4. 
 
AIM: To investigate the relationship between sexual function as assessed by the validated International Index of Erectile 
Function (IIEF-15) and T deficiency in HIV-infected men by assessing circulating T by Liquid Chromatography tandem Mass 
Spectrometry (LC-MS/MS). 
 
METHODOLOGY: Prospective, cross-sectional, observational study on 233 consecutive HIV-infected male patients with 
ongoing Highly Active Antiretroviral Therapy (HAART), attending the Clinic of Infectious Diseases. IIEF-15 questionnaire was 
used to define patients having ED (score <25), IIEF-5 was performed to check if it is reliable as IIEF-15 in this setting, while 
LC-MS/MS was used for hormonal assays. Statistical analysis: Continuous and categorical variables were compared using 
ANOVA univariate and Chi-Square test, respectively. Correlations were performed using Spearman’s Rho coefficient. 
 
RESULTS: 233 HIV-infected patients were enrolled (mean age 45.29±5.33 years) with average duration of HIV-infection of 
195.98±129.54 months. Eight patients (3.4%) had hypogonadism, defined as total T serum levels below 300 ng/dL. 142 
patients (61.5%) had ED (EF score ≤25) (Table 1). Age, hormonal data and duration of HIV infection and HAART did not 
differ among groups of patients according to the degree of ED (Table 1). 
 
Although no differences were seen among categories, the direct comparison of each ED cluster showed that months of 
infection were significantly higher in men with severe ED compared to mild ED (p=0.037); moreover, men with severe ED 
had lower T levels than men with mild form (p=0.029). All hypogonadal men had erectile dysfunction (p=0.020). However, no 
differences were found among ED degree for hypogonadal men (p=0.151). The erectile function domain at IIEF-15 was 
directly correlated with IIEF-5 score (0.778, p<0.001), as expected. Moreover, the IIEF-15 score was inversely related to 
months of infection (-0.147, p=0.026) (Figure 1), but not to months of HAART therapy (-0.121, p=0.071).  Total T showed an 
inverse relation with months of infection (-0.172, p=0.009) (Figure 1) and months of HAART (-0.173, p=0.010), but not with 
IIEF-15 score (0.039; p=0.559). 
 
CONCLUSIONS: To the best of our knowledge, 
this is the first, properly-designed prospective 
study aiming to investigate the relationship 
between erectile function and serum T, assessed 
using the LC-MS/MS in HIV-infected men. 
Similarly to the IIEF-15, the IIEF-5 recognize ED 
patients and the scores of both correlates each 
other. In our cohort, the prevalence of ED and 
hypogonadism was 61% and 3.4%, respectively. 
Thus, ED evaluated by IIEF-15 seems to be not 
directly related to serum total T, but it correlates 
with age and months of infection. In conclusion, in 
HIV-infected patients a) IIEF-5 is reliable as IIEF-
15 for ED diagnosis, b) ED is not associated with 
serum T, c) erectile function is not influenced by T 
and HAART, but only by HIV-infection duration. In 
conclusion, several specific factors, such as the 
duration of HIV infection, are involved in erectile 
function in HIV-infected men and should be 
carefully considered in this setting, while 
hormonal status seems to be less important. 
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Table 1 
Number of 
patients 
(%) 
IIEF-5 EF score at IIEF-15 
Age 
(years) 
Duration of 
HIV-infection 
(months) 
Testosterone 
(ng/dL) E2 (pg/ml) E2/T ratio 
None ED 89 (38.5) 23.0±2.0 28.4±1.4 44.8±5.4 185.0±108.7 672.4±235.1 27.1±9.9 0.004±0.001 
Mild ED 72 (31.2) 18.9±3.0 22.4±2.3 45.0±5.6 174.4±95.7 711.2±219.6 26.9±9.7 0.004±0.004 
Moderate ED 26 (11.3) 14.0±3.7 14.2±1.6 46.0±5.2 202.0±105.7 640.0±219.9 27.0±10.8 0.004±0.001 
Severe ED 44 (19.0) 10.9±7.9 4.9±2.9 46.4±4.6 222.7±95.6 602.2±201.1 23.7±9.7 0.004±0.002 
p-value - <0.001 <0.001 0.330 0.083 0.074 0.320 0.977 
Figure 1 

